Learn Mode

GMED - Globus Medical Inc

54

$94.87

$0.49 (0.519%)

At close: 4/24/26, 8:00 PM

Score

4.13/5

General

Scores

Financials & KPIs

Dividends

Analyst

Insider

GMED

Valuation Score

View as %

Stock Unlock

YTD

Max

Stock Profile

Market Cap

$12.81B

Industry

Health Care

EPS (TTM)

$3.93

P/E (TTM)

23.82

Div & Yield

FCF Payout Ratio

P/S (TTM)

4.36

P/B

2.80

Diluted Shares

136.57M

Ex-Dividend

Next Earnings

05-07

Forward P/E

19.97

Payout Ratio

P/FCF (TTM)

22.13

FCF Yield

4.52%

Earnings Yield

4.20%

52 Week Range

Score Card

Explore Scores Tab

4.13

Good

Globus Medical Inc has grown revenue at 16.65% over the past year, which is strong growth. Also, it has more cash than current liabilities meaning it has enough cash to handle all its debts within the next year, if it wanted to.

Valuation Model

Key Score

3.00

Average

Management

3.00

Average

Growth

4.00

Good

Profitability

4.00

Good

Fin. Health

4.00

Good

Dividends

Analyst

3.00

Average

Insider Transactions

Explore Insider Tab

Buy

Sell

Market News

Page 1 of 21

2 new filings were in the last 7 days

Filter Form Types

Form DEFA14A

Additional definitive proxy soliciting materials

Filed on 2026-04-24 16:06:06

Form DEF 14A

Also known as a 'definitive proxy statement', is a required filing when a shareholder vote is required

Filed on 2026-04-24 16:04:33

Form 144

Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-04-14 15:34:23

Form SCHEDULE 13G/A

Unknown Form Type

Filed on 2026-03-26 18:39:50

Form 8-K

Current report pursuant to Section 13 or 15(d)

Filed on 2026-03-23 17:26:25

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-02-27 17:53:36

Form 144

Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-02-25 15:41:00

Form 10-K

Annual financials report pursuant to Section 13 or 15(d)

Filed on 2026-02-24 17:08:45

Form 8-K

Current report pursuant to Section 13 or 15(d)

Filed on 2026-02-24 16:23:38

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-02-17 17:22:37

Form 144

Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-02-12 12:12:57

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-01-23 17:12:35

Page 1 of 21

Financials

Explore Financials Tab

Revenue

Earnings

Free Cash Flow

Price Targets

Go to Analyst Tab

These are one year price targets for: 2027-04-12

High:

$129.15

36.1%

Avg:

$108.12

14.0%

Low:

$78.78

-17.0%

(% change is relative to the current stock price: $94.87)

Analyst Recommendations

Go to Analyst Tab

3.91

Good

18%

Strong Buy (4)

55%

Buy (12)

27%

Hold (6)

Sell (0)

Strong Sell (0)

About

Website
https://www.globusmedical.com/
Address
2560 General Armistead Ave, Audubon PENNSYLVANIA, US
SEC Reports
https://sec.gov/edgar/browse/?CIK=1237831

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The company is headquartered in Audubon, Pennsylvania and currently employs 6,000 full-time employees. The company went IPO on 2012-03-08. The firm offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the conditions affecting the spine, including degenerative conditions, deformities, tumors, and trauma. The company provides solutions that facilitate both open and minimally invasive surgery techniques. The company includes traditional fusion implants, such as pedicle screws and rod systems, and others. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.

IPO Date

2012-03-08

Industry

Health Care

Total Employees

6,000

Exchange

New York Stock Exchange, Inc.

Reporting Currency

USD

GICS

Health Care Equipment & Supplies

GICS Sub

Health Care Equipment

GICS Sector

Health Care

GICS Group

Health Care Equipment & Services

GMED - Globus Medical Inc

54

$94.87

$0.49 (0.519%)

4.13/5

Stock Unlock

Stock Profile

Score Card

Good

Insider Transactions

Market News

Form DEFA14A

Filed on 2026-04-24 16:06:06

Form DEF 14A

Filed on 2026-04-24 16:04:33

Form 144

Filed on 2026-04-14 15:34:23

Form SCHEDULE 13G/A

Filed on 2026-03-26 18:39:50

Form 8-K

Filed on 2026-03-23 17:26:25

Form 4

Filed on 2026-02-27 17:53:36

Form 144

Filed on 2026-02-25 15:41:00

Form 10-K

Filed on 2026-02-24 17:08:45

Form 8-K

Filed on 2026-02-24 16:23:38

Form 4

Filed on 2026-02-17 17:22:37

Form 144

Filed on 2026-02-12 12:12:57

Form 4

Filed on 2026-01-23 17:12:35

Financials

Price Targets

36.1%

14.0%

-17.0%

Analyst Recommendations

About

Similar Stocks